KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Astrana Health (ASTH) Income from Non-Controlling Interests (2016 - 2025)

Astrana Health's Income from Non-Controlling Interests history spans 12 years, with the latest figure at $704000.0 for Q3 2025.

  • For Q3 2025, Income from Non-Controlling Interests fell 75.61% year-over-year to $704000.0; the TTM value through Sep 2025 reached $200000.0, up 104.13%, while the annual FY2024 figure was $6.8 million, 336.51% up from the prior year.
  • Income from Non-Controlling Interests for Q3 2025 was $704000.0 at Astrana Health, down from $793000.0 in the prior quarter.
  • Across five years, Income from Non-Controlling Interests topped out at $46.9 million in Q2 2021 and bottomed at -$39.7 million in Q3 2021.
  • The 5-year median for Income from Non-Controlling Interests is $712000.0 (2022), against an average of -$928894.7.
  • The largest annual shift saw Income from Non-Controlling Interests plummeted 1224.03% in 2021 before it surged 740.71% in 2023.
  • A 5-year view of Income from Non-Controlling Interests shows it stood at -$31.4 million in 2021, then surged by 109.07% to $2.8 million in 2022, then crashed by 537.61% to -$12.4 million in 2023, then surged by 93.37% to -$826000.0 in 2024, then surged by 185.23% to $704000.0 in 2025.
  • Per Business Quant, the three most recent readings for ASTH's Income from Non-Controlling Interests are $704000.0 (Q3 2025), $793000.0 (Q2 2025), and -$471000.0 (Q1 2025).